Observational studyCurrent oncology (Toronto, Ont.)2022

The Impact of Real-World Alternative Dosing Strategies of Palbociclib on Progression-Free Survival in Patients with Metastatic Breast Cancer.

Fulbert Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.